AURKAIP1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	34 studies	30% ± 9%	Explore
B cell	30 studies	28% ± 10%	Explore
endothelial cell	29 studies	32% ± 13%	Explore
fibroblast	29 studies	29% ± 13%	Explore
CD4-positive, alpha-beta T cell	28 studies	30% ± 16%	Explore
T cell	27 studies	30% ± 10%	Explore
macrophage	27 studies	31% ± 10%	Explore
CD8-positive, alpha-beta T cell	27 studies	32% ± 16%	Explore
conventional dendritic cell	25 studies	34% ± 15%	Explore
classical monocyte	24 studies	35% ± 14%	Explore
pericyte	24 studies	31% ± 9%	Explore
smooth muscle cell	22 studies	31% ± 10%	Explore
non-classical monocyte	22 studies	36% ± 15%	Explore
regulatory T cell	21 studies	34% ± 10%	Explore
epithelial cell	19 studies	46% ± 18%	Explore
plasmacytoid dendritic cell	18 studies	30% ± 11%	Explore
monocyte	17 studies	35% ± 9%	Explore
basal cell	17 studies	39% ± 17%	Explore
memory B cell	16 studies	26% ± 8%	Explore
endothelial cell of lymphatic vessel	15 studies	34% ± 11%	Explore
plasma cell	15 studies	49% ± 16%	Explore
ciliated cell	15 studies	51% ± 17%	Explore
gamma-delta T cell	15 studies	32% ± 13%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	30% ± 9%	Explore
naive B cell	14 studies	22% ± 4%	Explore
mature NK T cell	14 studies	29% ± 6%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	13 studies	25% ± 5%	Explore
myofibroblast cell	13 studies	27% ± 9%	Explore
connective tissue cell	13 studies	33% ± 9%	Explore
mast cell	12 studies	24% ± 7%	Explore
plasmablast	12 studies	53% ± 24%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	30% ± 12%	Explore
dendritic cell	12 studies	40% ± 24%	Explore
capillary endothelial cell	12 studies	26% ± 7%	Explore
secretory cell	11 studies	36% ± 18%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	31% ± 8%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	31% ± 8%	Explore
vein endothelial cell	11 studies	27% ± 8%	Explore
myeloid cell	11 studies	39% ± 16%	Explore
abnormal cell	10 studies	37% ± 15%	Explore
endothelial cell of artery	10 studies	28% ± 8%	Explore
mucosal invariant T cell	10 studies	27% ± 3%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	31% ± 12%	Explore
effector memory CD8-positive, alpha-beta T cell	9 studies	28% ± 12%	Explore
progenitor cell	9 studies	45% ± 14%	Explore
goblet cell	9 studies	43% ± 17%	Explore
endothelial cell of vascular tree	9 studies	29% ± 5%	Explore
type I pneumocyte	8 studies	31% ± 12%	Explore
type II pneumocyte	7 studies	37% ± 17%	Explore
innate lymphoid cell	7 studies	33% ± 8%	Explore
T follicular helper cell	7 studies	25% ± 4%	Explore
club cell	6 studies	45% ± 6%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	41% ± 13%	Explore
leukocyte	6 studies	33% ± 11%	Explore
epithelial cell of proximal tubule	6 studies	47% ± 10%	Explore
renal alpha-intercalated cell	6 studies	56% ± 11%	Explore
neuron	6 studies	43% ± 20%	Explore
enterocyte	6 studies	51% ± 13%	Explore
mesothelial cell	6 studies	35% ± 17%	Explore
IgG plasma cell	6 studies	27% ± 11%	Explore
transit amplifying cell	6 studies	45% ± 23%	Explore
erythrocyte	6 studies	32% ± 19%	Explore
alveolar macrophage	5 studies	26% ± 5%	Explore
hematopoietic precursor cell	5 studies	43% ± 20%	Explore
exhausted T cell	5 studies	44% ± 14%	Explore
ionocyte	5 studies	42% ± 11%	Explore
respiratory goblet cell	5 studies	46% ± 20%	Explore
mononuclear phagocyte	5 studies	36% ± 16%	Explore
kidney loop of Henle epithelial cell	5 studies	48% ± 3%	Explore
kidney distal convoluted tubule epithelial cell	5 studies	48% ± 7%	Explore
enteroendocrine cell	5 studies	47% ± 19%	Explore
IgA plasma cell	5 studies	26% ± 9%	Explore
retinal ganglion cell	5 studies	66% ± 31%	Explore
precursor B cell	5 studies	32% ± 11%	Explore
pro-B cell	5 studies	28% ± 8%	Explore
brush cell	5 studies	32% ± 17%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	40% ± 16%	Explore
deuterosomal cell	4 studies	55% ± 21%	Explore
intestinal crypt stem cell	4 studies	43% ± 15%	Explore
retinal cone cell	4 studies	54% ± 24%	Explore
retinal rod cell	4 studies	35% ± 13%	Explore
erythroblast	4 studies	43% ± 21%	Explore
hematopoietic stem cell	4 studies	26% ± 11%	Explore
amacrine cell	4 studies	41% ± 18%	Explore
astrocyte	4 studies	36% ± 17%	Explore
adventitial cell	4 studies	20% ± 6%	Explore
mucus secreting cell	4 studies	36% ± 17%	Explore
CD4-positive helper T cell	4 studies	24% ± 4%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	43% ± 7%	Explore
intermediate monocyte	4 studies	48% ± 16%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	53% ± 4%	Explore
hepatocyte	4 studies	44% ± 30%	Explore
T-helper 17 cell	4 studies	39% ± 21%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	25% ± 3%	Explore
duct epithelial cell	3 studies	41% ± 11%	Explore
pancreatic A cell	3 studies	57% ± 24%	Explore
type B pancreatic cell	3 studies	49% ± 23%	Explore
podocyte	3 studies	42% ± 7%	Explore
neural crest cell	3 studies	44% ± 1%	Explore
retinal bipolar neuron	3 studies	48% ± 18%	Explore
OFF-bipolar cell	3 studies	49% ± 32%	Explore
ON-bipolar cell	3 studies	51% ± 32%	Explore
renal principal cell	3 studies	46% ± 3%	Explore
extravillous trophoblast	3 studies	53% ± 15%	Explore
placental villous trophoblast	3 studies	72% ± 10%	Explore
lymphocyte	3 studies	42% ± 12%	Explore
megakaryocyte	3 studies	24% ± 6%	Explore
neuroendocrine cell	3 studies	53% ± 19%	Explore
immature B cell	3 studies	26% ± 6%	Explore
retina horizontal cell	3 studies	43% ± 17%	Explore
microglial cell	3 studies	26% ± 10%	Explore
serous secreting cell	3 studies	46% ± 10%	Explore
intraepithelial lymphocyte	3 studies	30% ± 9%	Explore
Mueller cell	3 studies	43% ± 11%	Explore
germinal center B cell	3 studies	35% ± 3%	Explore
myoepithelial cell	3 studies	31% ± 12%	Explore
IgM plasma cell	3 studies	32% ± 9%	Explore
oligodendrocyte precursor cell	3 studies	27% ± 6%	Explore
granulocyte monocyte progenitor cell	3 studies	45% ± 24%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	38% ± 19%	Explore
neutrophil	3 studies	21% ± 0%	Explore
glial cell	3 studies	35% ± 21%	Explore
group 3 innate lymphoid cell	3 studies	37% ± 15%	Explore
keratinocyte	3 studies	31% ± 3%	Explore
T-helper 1 cell	3 studies	38% ± 12%	Explore
double negative thymocyte	3 studies	41% ± 20%	Explore
progenitor cell of mammary luminal epithelium	3 studies	30% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	17 studies	32% ± 11%	Explore
lung	16 studies	38% ± 15%	Explore
intestine	11 studies	34% ± 17%	Explore
kidney	8 studies	35% ± 7%	Explore
eye	7 studies	34% ± 15%	Explore
liver	7 studies	32% ± 21%	Explore
lymph node	5 studies	36% ± 15%	Explore
brain	5 studies	25% ± 4%	Explore
uterus	4 studies	38% ± 19%	Explore
breast	4 studies	32% ± 4%	Explore
pancreas	3 studies	51% ± 24%	Explore
placenta	3 studies	52% ± 20%	Explore
bone marrow	3 studies	28% ± 7%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
adrenal gland	100%	4638.24	258 / 258	100%	156.10	230 / 230
esophagus	100%	3715.33	1445 / 1445	100%	109.46	183 / 183
liver	100%	4260.31	226 / 226	100%	169.40	406 / 406
ovary	100%	2170.81	180 / 180	100%	187.15	430 / 430
pancreas	100%	2523.87	328 / 328	100%	144.51	178 / 178
thymus	100%	3530.27	653 / 653	100%	162.90	605 / 605
uterus	100%	2679.41	170 / 170	100%	224.44	459 / 459
brain	100%	4038.89	2640 / 2642	100%	148.26	705 / 705
skin	100%	3794.75	1809 / 1809	100%	186.23	470 / 472
stomach	100%	3583.60	359 / 359	99%	149.58	284 / 286
prostate	100%	3516.98	245 / 245	99%	191.30	498 / 502
intestine	100%	4060.52	966 / 966	99%	183.57	522 / 527
kidney	100%	5067.61	89 / 89	99%	126.16	892 / 901
bladder	100%	3375.57	21 / 21	98%	206.07	496 / 504
lung	100%	2834.73	576 / 578	98%	135.02	1135 / 1155
breast	100%	3599.43	459 / 459	97%	140.82	1082 / 1118
adipose	100%	3582.88	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	193.39	80 / 80
lymph node	0%	0	0 / 0	100%	267.35	29 / 29
muscle	100%	5938.82	803 / 803	0%	0	0 / 0
spleen	100%	3634.21	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	179.30	45 / 45
ureter	0%	0	0 / 0	100%	215.40	1 / 1
blood vessel	100%	2793.04	1330 / 1335	0%	0	0 / 0
heart	99%	5272.49	854 / 861	0%	0	0 / 0
peripheral blood	98%	3705.21	914 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

GO_0032543	Biological process	mitochondrial translation
GO_0045839	Biological process	negative regulation of mitotic nuclear division
GO_0045862	Biological process	positive regulation of proteolysis
GO_0043231	Cellular component	intracellular membrane-bounded organelle
GO_0005654	Cellular component	nucleoplasm
GO_0005759	Cellular component	mitochondrial matrix
GO_0005763	Cellular component	mitochondrial small ribosomal subunit
GO_0005743	Cellular component	mitochondrial inner membrane
GO_0005739	Cellular component	mitochondrion
GO_0005634	Cellular component	nucleus
GO_0005515	Molecular function	protein binding

Gene name	AURKAIP1
Protein name	Small ribosomal subunit protein mS38 Small ribosomal subunit protein mS38 (28S ribosomal protein S38, mitochondrial) (MRP-S38) (Aurora kinase A-interacting protein) (AURKA-interacting protein)
Synonyms	AIP MRPS38 AKIP
Description	FUNCTION: May act as a negative regulator of Aurora-A kinase, by down-regulation through proteasome-dependent degradation.
Accessions	Q6PI41 ENST00000338370.7 Q9NWT8 ENST00000378853.3 ENST00000338338.10 ENST00000321751.9

AURKAIP1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review